Trial intelligence / Profile preview

Dexmedetomidine for Postoperative Sleep Quality in Elderly Patients

NCT03117790Phase 4Completed

Sponsor
Peking University First Hospital
Start
Jun 2017
Primary completion
Jan 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of dexmedetomidine in Postoperative sleep disturbance (PSD), sponsored by Peking University First Hospital. Started Jun 2017; status: completed.

02

Drugs

dexmedetomidine
03

Conditions

Postoperative sleep disturbance (PSD)

Beyond the preview

Go deeper on NCT03117790.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03117790.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call